ABU DHABI / GULF TIME In a groundbreaking moment for luxury real estate, the German ...
Read More »Rebiotix drug to keep infection recurrences away
Bloomberg Rebiotix Inc., a closely held biotechnology company, said its drug that restores beneficial gut bacteria was better than a placebo at keeping life-threatening intestinal infections from recurring in a human trial. Recurrences of infections with Clostridium difficile, a potentially deadly microbe that often attacks sick, hospitalized patients, were prevented in 63.9 percent of people who took the drug, ...
Read More »